REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioinfra Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing | Scientific Research and Development Services
Full name: Bioinfra Co.,Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Bioinfra Co.,Ltd. is based in South Korea. The head office is in Yongin. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was established on May 23, 2007. It currently has a total number of 103 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 15.94% in 2022. Over the same period, its total assets decreased by 3.41%. In, 2022, the company’s net profit margin decreased by 2.79%.

Headquarters
5F, Heungdeok U-Tower, 120, Heungdeokjungang-Ro, Giheung-Gu
Yongin; Gyeonggi;

Contact Details: Purchase the Bioinfra Co.,Ltd. report to view the information.

Website: http://bioinfrakorea.co.kr

Basic Information
Total Employees:
Purchase the Bioinfra Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Bioinfra Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Bioinfra Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Bioinfra Co.,Ltd. report to view the information.
Incorporation Date:
May 23, 2007
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Company Performance
Financial values in the chart are available after Bioinfra Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
15.94%
Total Operating Revenue
15.94%
Operating Profit
-14.77%
EBITDA
-3.5%
Net Profit/Loss for the Period
0.05%
Total Assets
-3.41%
Total Equity
64.88%
Operating Profit Margin
-6.47%
Net Profit Margin
-2.79%
Return on Equity (ROE)
-22.56%
Debt / Equity
-87.37%
Quick Ratio
-0.04%
Cash Ratio
0.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?